Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
08 Enero 2024 - 7:00AM
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL)
announced today that it will present at the 42nd Annual J.P. Morgan
Healthcare Conference on Tuesday, January 9th, at 10:30 a.m. PST
(1:30 p.m. EST). Management will present an overview of Charles
River’s strategic focus, business developments, and recent
trends.
A live webcast of the presentation will be available through a
link that will be posted on the Investor Relations section of the
Charles River website at ir.criver.com. A webcast replay will be
accessible through the same website after the presentation and will
remain available for at least two weeks.
About Charles River
Charles River provides essential products and services to help
pharmaceutical and biotechnology companies, government agencies and
leading academic institutions around the globe accelerate their
research and drug development efforts. Our dedicated employees are
focused on providing clients with exactly what they need to improve
and expedite the discovery, early-stage development and safe
manufacture of new therapies for the patients who need them. To
learn more about our unique portfolio and breadth of services,
visit www.criver.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240108499021/en/
Investor Relations Contact: Todd Spencer Corporate Vice
President, Investor Relations 781.222.6455 todd.spencer@crl.com
Charles River Laboratories (NYSE:CRL)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Charles River Laboratories (NYSE:CRL)
Gráfica de Acción Histórica
De May 2023 a May 2024